Purchase Order 75N91024P00270
Award Date
3/1/24
Potential Completion Date
9/1/24
Potential Value
$25K
Federal Agency
National Cancer Institute
Awardee
Engene Statistics GMBH
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Switzerland
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Cancer Institute within the National Institutes of Health, part of the Department of Health and Human Services. The $20,000 contract requires Engene to provide laboratory testing services in support of biomedical research projects involving high throughput data analysis. Performance will take place at the National Cancer Institute location in Bethesda, Maryland and...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Cancer Institute within the National Institutes of Health, Department of Health and Human Services. The $25,000 purchase order is for testing services to support research efforts through January 31, 2025 with no set aside designation applied. As a privately owned data analytics and statistical consulting company based in Switzerland, Engene Statistics Sagl will...
Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Institutes of Health's National Cancer Institute to provide testing services in support of biomedical research projects involving high throughput data analysis. With a potential value of $19,123, this purchase order has a completion date of March 14, 2024 and was awarded on November 1, 2023. No major subcontractors or set aside designations were specified. Engene...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order for $1 million to $5 million to Engene Statistics Sagl of Switzerland for laboratory testing services. Under this contract, Engene Statistics will provide testing support to advance the National Cancer Institute's biomedical research mission. As a small business located in Switzerland, Engene Statistics will leverage their scientific expertise to help...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, to Engene Statistics GMBH, doing business as Engene Statistics Sagl, a for-profit organization based in Switzerland. The $23,530.37 contract is for laboratory testing services to support biomedical research projects involving high throughput data analysis, particularly in the field of cancer...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,407 purchase order to Engene Statistics Sagl of Switzerland for testing services. Under the firm fixed price contract, Engene Statistics Sagl will provide unspecified testing services to the National Cancer Institute from July 31, 2023 through October 31, 2023. The contract was awarded directly to Engene Statistics Sagl as the prime contractor, with no mention of major...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Genus Biosystems Inc., a for-profit organization, for $23,520.00 to provide lab testing services. The contract has a completion date of November 1, 2024 and was awarded on May 1, 2024. The place of performance is Northbrook, IL 60062, USA. This contract award is not associated with any set-aside designation.</p>
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $25,000 purchase order to Nanostring Technologies, Inc. for testing services. The firm fixed price contract will be performed in Seattle, Washington over a four month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's biomedical research mission. No subcontractors or set aside designations...
The National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,225 firm fixed-price purchase order contract to N-Of-One, Inc., a self-certified small disadvantaged business, for laboratory testing services. This is the fifth prime federal contract awarded to N-Of-One by the National Cancer Institute between 2019 and 2020, with a total potential value across the awards of $89,700. The contract has an ultimate completion date of September...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $86,760 firm fixed price delivery order contract to Steinbeis GMBH & CO. KG FÜR Technologietransfer of Almanya for assay services. As the prime contractor, Steinbeis will provide testing and analysis for the National Institute of Environmental Health Sciences through October 2, 2024. The contract was awarded on April 3, 2023 without a set-aside...